Short Interest in Moolec Science SA (NASDAQ:MLEC) Rises By 128.4%

Moolec Science SA (NASDAQ:MLEC) saw a significant growth in short interest during the month of June. As of June 15th, there was short interest totaling 20,742 shares, a growth of 128.4% from the May 31st total of 9,082 shares. Currently, 3.6% of the shares of the company are sold short. Based on an average trading volume of 37,357 shares, the days-to-cover ratio is currently 0.6 days.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded Moolec Science from a “sell” rating to a “hold” rating in a report on Saturday, May 16th.

Moolec Science Stock Performance

MLEC traded up $0.49 during trading on Monday, hitting $8.09. 6,525 shares of the company traded hands, compared to its average volume of 817,005. The firm has a market cap of $5.91 million, a P/E ratio of -0.25 and a beta of 0.28. The stock’s fifty day moving average is $7.90 and its 200 day moving average is $7.58. The company has a quick ratio of 0.08, a current ratio of 0.15 and a debt-to-equity ratio of 0.79. Moolec Science has a one year low of $3.08 and a one year high of $102.00.

Moolec Science (NASDAQ:MLEC) last posted its quarterly earnings data on Thursday, May 14th. The company reported $47.49 earnings per share (EPS) for the quarter. The company had revenue of $2.62 million for the quarter.

Institutional Investors Weigh In On Moolec Science

An institutional investor recently bought a new stake in Moolec Science stock. Citadel Advisors LLC purchased a new position in Moolec Science SA (NASDAQ:MLEC) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science at the end of the most recent quarter. Institutional investors own 0.07% of the company’s stock.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.